GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses
Open accessThe DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
Tremendous amount of RNA sequencing data have been produced by large consortium projects such as TCGA and GTEx, creating new opportunities for data mining and deeper understanding of gene functions. While certain existing web servers are valuable and widely used, many expression analysis functions needed by experimental biologists are still not adequately addressed by these tools. We introduce GEPIA (Gene Expression Profiling Interactive Analysis), a web-based tool to deliver fast and customizable functionalities based on TCGA and GTEx data. GEPIA provides key interactive and customizable functions including differential expression analysis, profiling plotting, correlation analysis, patient survival analysis, similar gene detection and dimensionality reduction analysis. The comprehensive expression analyses with simple clicking through GEPIA greatly facilitate data mining in wide research areas, scientific discussion and the therapeutic discovery process. GEPIA fills in the gap between cancer genomics big data and the delivery of integrated information to end users, thus helping unleash the value of the current data resources. GEPIA is available at http://gepia.cancer-pku.cn/.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“A comprehensive analysis of the correlation between expression levels of these genes and ENO1 in liver cancer (Figure 1B; Tang et al., 2017) as well as the association between high or low expression level of these genes and hepatocellular carcinoma (HCC) prognosis (Figure 1C; Menyhart et al., 2018) revealed that GAPDH, BACE2, and TRIM36 were the top 3 genes (Figure 1D; Supplementary Figure S1A).”
From ENO1–BACE2-mediated LDLR cleavage promotes liver cancer progression by remodelling cholesterol metabolism (2025) · cites this paper as Tang et al., 2017
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Our analysis of genomic alterations in glioblastoma according to data in the Cancer Genome Atlas (TCGA) identified the q13–15 region of chromosome 12 as one of the regions that most often rearranged in the disease (Fig. 1A and B)5, 6, 7.”
From Rational drug design, synthesis, and biological evaluation of novel chiral tetrahydronaphthalene-fused spirooxindole as MDM2-CDK4 dual inhibitor against glioblastoma (2020) · cites this paper as [6]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tissue-based map of the human proteome
Uhlén, M., Fagerberg, L., Hallström, B. M., Lindskog, C., Oksvold, P., Mardinoglu, A., Sivertsson, Å., Kampf, C., Sjöstedt, E., Asplund, A., et al. (2015) · Science · doi:10.1126/science.1260419 · Cited by 15,286
RNA-Seq: a revolutionary tool for transcriptomics
Wang, Z., Gerstein, M., & Snyder, M. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2484 · Cited by 13,174 · cited 1×
“High-throughput RNA sequencing (RNA-Seq) has emerged as a powerful method for transcriptomic analysis (1), widely used for understanding gene functions and biological patterns, finding candidate drug targets and identifying biomarkers for disease classification and diagnosis (2).”
MethodThe cancer genome atlas pan-cancer analysis project
The Cancer Genome Atlas Research Network, Weinstein, J. N., Collisson, E. A., Mills, G. B., Shaw, K. R. M., Ozenberger, B. A., Ellrott, K., Shmulevich, I., Sander, C., & Stuart, J. M. (2013) · Nature Genetics · doi:10.1038/ng.2764 · Cited by 9,092 · cited 9×
“To solve the imbalance between the tumor and normal data which can cause inefficiency in various differential analyses, we download the TCGA and GTEx gene expression data that are re-computed from raw RNA-Seq data by the UCSC Xena project based on a uniform pipeline (Figure 1).”
BackgroundInfluentialThe Genotype-Tissue Expression (GTEx) pilot analysis: Multitissue gene regulation in humans
The GTEx Consortium, Ardlie, K. G., Deluca, D. S., Segrè, A. V., Sullivan, T. J., Young, T. R., Gelfand, E. T., Trowbridge, C. A., Maller, J. B., Tukiainen, T., et al. (2015) · Science · doi:10.1126/science.1262110 · Cited by 5,062
Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer
Tomlins, S. A., Rhodes, D. R., Perner, S., Dhanasekaran, S. M., Mehra, R., Sun, X.-W., Varambally, S., Cao, X., Tchinda, J., Kuefer, R., et al. (2005) · Science · doi:10.1126/science.1117679 · Cited by 3,846
Welsh, J. B., Sapinoso, L. M., Su, A. I., Kern, S. G., Wang‐Rodriguez, J., Moskaluk, C. A., Frierson, H. F., & Hampton, G. M. (2001) · PubMed · Cited by 856
Regulatory T Cells Exhibit Distinct Features in Human Breast Cancer
Plitas, G., Konopacki, C., Wu, K., Bos, P. D., Morrow, M., Putintseva, E. V., Chudakov, D. M., & Rudensky, A. Y. (2016) · Immunity · doi:10.1016/j.immuni.2016.10.032 · Cited by 695 · cited 1×
“Survival analysis based on gene expression levels is also widely used for evaluating the clinical importance of a given gene (11).”
Welsh, J. B., Zarrinkar, P. P., Sapinoso, L. M., Kern, S. G., Behling, C. A., Monk, B. J., Lockhart, D. J., Burger, R. A., & Hampton, G. M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.3.1176 · Cited by 654
Revisiting Global Gene Expression Analysis
Lovén, J., Orlando, D. A., Sigova, A. A., Lin, C. Y., Rahl, P. B., Burge, C. B., Levens, D. L., Lee, T. I., & Young, R. A. (2012) · Cell · doi:10.1016/j.cell.2012.10.012 · Cited by 616 · cited 1×
“High-throughput RNA sequencing (RNA-Seq) has emerged as a powerful method for transcriptomic analysis (1), widely used for understanding gene functions and biological patterns, finding candidate drug targets and identifying biomarkers for disease classification and diagnosis (2).”
MethodPetryszak, R., Keays, M., Tang, Y. A., Fonseca, N. A., Barrera, E., Burdett, T., Füllgrabe, A., Fuentes, A. M.-P., Jupp, S., Koskinen, S., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1045 · Cited by 530 · cited 5×
“org/), HPA (12) and Expression Atlas (13) have provided many useful visualization and analysis tools for gene expression analysis.”
MethodInfluential
Cited by
Items 501–600 of 1,028
Dzobo, K., & Sinkala, M. (2021) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2021.0025 · Cited by 69
“…The Cancer Genome Atlas (TCGA) (https:// cancergenome.nih.gov), Gene Expression Profiling Inter-active Analysis (GEPIA) (https://gepia.cancer-pku.cn) (Tang et al., 2017), Oncomine database (https://www.oncomine .org), Tumor Immune Estimation Resource (TIMER) database (https://cistrome.org/TIMER/),…”
Integrin alpha-V is an important driver in pancreatic adenocarcinoma progression
Kemper, M., Schiecke, A., Maar, H., Nikulin, S. V., Poloznikov, A. A., Galatenko, V., Tachezy, M., Gebauer, F., Lange, T., Riecken, K., et al. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-01946-2 · Cited by 68
“3, [30]) and Human Protein Atlas [31], which show a correlation between ITGAV mRNA expression level and poor patient survival.”
BackgroundZhu, H., Hu, X., Gu, L., Jian, Z., Li, L., Hu, S., Qiu, S., & Xiong, X. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.759953 · Cited by 63
Song, Y. H., Chen, J., Zhang, C., Lei, X., Li, Q., Liu, Y., Zhang, C., Li, S., & Huang, P. (2022) · iScience · doi:10.1016/j.isci.2022.103733 · Cited by 63
“GEPIA is an interactive web application for gene expression analysis based on RNA sequencing data of tumors and normal samples from the TCGA and the GTEx databases (Tang et al., 2017).”
MethodTargeting colorectal cancer with small-molecule inhibitors of ALDH1B1
Feng, Z., Hom, M. E., Bearrood, T. E., Rosenthal, Z. C., Fernández, D., Ondrus, A. E., Gu, Y., McCormick, A. K., Tomaske, M. G., Marshall, C. R., et al. (2022) · Nature Chemical Biology · doi:10.1038/s41589-022-01048-w · Cited by 65
Dixit, A. K., Sarver, A. G., Zettervall, J., Huang, H., Zheng, K., Brekken, R. A., & Provenzano, P. P. (2022) · JCI Insight · doi:10.1172/jci.insight.153242 · Cited by 64
“Correlation analysis was performed using the GEPIA platform(66).”
Mishra, D., Mishra, A., Nand, S., Vamanu, E., & Singh, M. P. (2023) · Diagnostics · doi:10.3390/diagnostics13050965 · Cited by 63
“The gene expression profiles of normal and cancerous TCGA samples related to all the 13 hub genes in both GBM and HCC were obtained through GEPIA (Gene Expression Profiling Interactive Analysis), an online web server (Tang et al., 2017).”
MethodSNCA Is a Functionally Low-Expressed Gene in Lung Adenocarcinoma
Yan, Y., Xu, Z., Hu, X., Qian, L., Li, Z., Zhou, Y., Dai, S., Zeng, S., & Gong, Z. (2018) · Genes · doi:10.3390/genes9010016 · Cited by 64
“The gene expression profiling interactive analysis (GEPIA) [17] and PhosphoNET databases [18] were used to study how SNCA may be regulated by EGFR in ADC.”
MethodZhang, T., Guo, J., Gu, J., Wang, Z., Wang, G., Li, H., & Wang, J. (2018) · Oncology Reports · doi:10.3892/or.2018.6840 · Cited by 67
“html) is an online tool, which delivers fast and customizable analysis for RNA sequencing expression data based on The Cancer Genome Atlas and GTEx databases, which include data on 9,736 tumors and 8,587 normal samples (28).”
MethodHDAC3 modulates cancer immunity via increasing PD-L1 expression in pancreatic cancer
Hu, G., He, N., Cai, C., Cai, F., Fan, P., Zheng, Z., & Jin, X. (2019) · Pancreatology · doi:10.1016/j.pan.2019.01.011 · Cited by 64
HSF2BP Interacts with a Conserved Domain of BRCA2 and Is Required for Mouse Spermatogenesis
Brandsma, I., Sato, K., van Rossum-Fikkert, S. E., van Vliet, N., Sleddens, E., Reuter, M., Odijk, H., van den Tempel, N., Dekkers, D. H. W., Bezstarosti, K., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.05.096 · Cited by 61
Wang, Y., Chen, L., Ju, L., Qian, K., Liu, X., Wang, X., & Xiao, Y. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01030 · Cited by 66
“Finally, we used the Gene Expression Profiling Interactive Analysis (GEPIA) database (31) (http://gepia.”
MethodWang, D., Liu, J., Liu, S., & Li, W. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.00342 · Cited by 69
SIRT7 Is a Prognostic Biomarker Associated With Immune Infiltration in Luminal Breast Cancer
Huo, Q., Li, Z., Cheng, L., Yang, F., & Xie, N. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00621 · Cited by 69
“The analysis results included ∼20,000 coding genes, ∼25,000 non-coding genes, ∼14,000 pseudogenes, and ∼400 Tcell receptor fragments (26).”
BackgroundZhang, J., Wu, Y., Lin, Y.-H., Guo, S., Ning, P.-F., Zheng, Z., Wang, Y., & Zhao, Y. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i22.2381 · Cited by 65
High expression of RAD51 promotes DNA damage repair and survival in KRAS-mutant lung cancer cells
Hu, J., Zhang, Z., Zhao, L., Li, L., Zuo, W., & Han, L. (2019) · BMB Reports · doi:10.5483/bmbrep.2019.52.2.213 · Cited by 62
“cn/) (28), a web-based interactive toolkit for cancer gene expression profiling datasets with default parameters.”
BackgroundSelf-citationCancer immunotherapy based on blocking immune suppression mediated by an immune modulator LAIR-1
Xu, L., Wang, S., Li, J., Li, J., & Li, B. (2020) · OncoImmunology · doi:10.1080/2162402x.2020.1740477 · Cited by 67
MARCKS cooperates with NKAP to activate NF-kB signaling in smoke-related lung cancer
Liu, J., Chen, S.-J., Hsu, S., Zhang, J., Li, J.-M., Yang, D. C. H., Gu, S. V., Pinkerton, K. E., & Chen, C. (2021) · Theranostics · doi:10.7150/thno.53558 · Cited by 66
“Data from Gene Expression Profiling Interactive Analysis (GEPIA) [25] analysis confirmed a significantly positive correlation of MARCKS expression with TNFR, RELA, BCL2A1, CXCL1, RELB or TNF-alpha in lung cancer samples but not in normal lung tissues (Figure S4A).”
MethodChen, W., Dong, K., Pan, X., Gan, S., Xu, D., Chen, J.-X., Chen, W., Li, W., Wang, Y., Wang, Z., et al. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-05566-w · Cited by 68
“The results showed that RCC cell migration and invasion were signi fi cantly decreased in sh-SERPINE2 group (Fig.”
Chen, J., Hong, J. H., Huang, Y., Liu, S., Yin, J., Deng, P., Sun, Y.-C., Yu, Z., Zeng, X., Xiao, R., et al. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01786-y · Cited by 64
“Furthermore, we showed that in both The Cancer Genome Atlas (TCGA) and Genotype-Tissue Expression (GTEx) projects [22] and in our own in-house data, EZH2 was overexpressed in OC tissues compared to the normal tissues, whereas the H3K27me3 level was decreased in OC tissues compared to normal fallopian tube tissues (Fig.”
ResultLi, B., Pu, K., & Wu, X. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28420 · Cited by 62
Expression and prognostic analyses of ITGA11 , ITGB4 and ITGB8 in human non-small cell lung cancer
Wu, P., Wang, Y., Wu, Y., Jia, Z., Song, Y., & Liang, N. (2019) · PeerJ · doi:10.7717/peerj.8299 · Cited by 64
Gupta, R., Leon, F., Thompson, C. M., Nimmakayala, R. K., Karmakar, S., Nallasamy, P., Chugh, S., Prajapati, D. R., Rachagani, S., Sushil Kumar, K., et al. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-0772-3 · Cited by 66
Zhao, R., Tian, L., Zhao, B., Sun, Y., Cao, J., Chen, K., Li, F., Li, M., Shang, D., & Liu, M. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2457-5 · Cited by 62
The DDX39B/FUT3/TGFβR-I axis promotes tumor metastasis and EMT in colorectal cancer
He, C., Li, A., Lai, Q., Ding, J. P., Yan, Q., Liu, S., & Li, Q. (2021) · Cell Death and Disease · doi:10.1038/s41419-020-03360-6 · Cited by 64
Shen, D., Ding, L., Lu, Z., Wang, R., Yu, C., Wang, H., Zheng, Q., Wang, X., Xu, W., Yu, H., et al. (2021) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2021.12.024 · Cited by 63
“They provide key interactive and customizable functions, including differential expression analysis, correlation analysis, and patient survival analysis.(46,47) The online tool catRAPID (http://s.”
MethodWu, L., Zhou, Z., Han, S., Chen, J., Liu, Z., Zhang, X., Yuan, W., Ji, J., & Shu, X. (2019) · British Journal of Cancer · doi:10.1038/s41416-019-0679-z · Cited by 61
Du, J., Hou, K., Mi, S., Ji, H., Ma, S., Ba, Y., Hu, S., Xie, R., & Chen, L. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00208 · Cited by 66
“To comprehensively understand the function of METTL3, we retrieved the expression levels of healthy tissue and tumor tissue in different parts from the GTEx and GEPIA databases (48), respectively.”
MethodPrediction and interpretation of cancer survival using graph convolution neural networks
Ramirez, R., Chiu, Y., Zhang, S., Ramirez, J., Chen, Y., Huang, Y., & Jin, Y.-F. (2021) · Methods · doi:10.1016/j.ymeth.2021.01.004 · Cited by 67
Yen, Y., Chien, M., Wu, P., Ho, C.-C., Ho, C.-T., Huang, K. C., Chiang, S., Chao, K., Chen, W. T., & Hung, S. (2021) · Nature Communications · doi:10.1038/s41467-021-27620-x · Cited by 64
Chang, C., Rajasekaran, M., Qiao, Y., Dong, H., Wang, Y., Xia, H., Deivasigamani, A., Wu, M., Sekar, K., Gao, H., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29016-x · Cited by 61
Loss of KMT5C Promotes EGFR Inhibitor Resistance in NSCLC via LINC01510-Mediated Upregulation of MET
Pal, A. S., Agredo, A., Lanman, N. A., Son, J., Sohal, I. S., Bains, M., Li, C., Clingerman, J., Gates, K., & Kasinski, A. L. (2022) · Cancer Research · doi:10.1158/0008-5472.can-20-0821 · Cited by 67
Self-citationDi, Y., Jing, X., Hu, K., Wen, X., Ye, L., Zhang, X., Qin, J., Ye, J., Lin, R., Wang, Z., et al. (2022) · Drug Resistance Updates · doi:10.1016/j.drup.2022.100909 · Cited by 62
Ming-shan, L., Liu, Y., Zhang, X., Liu, J., & Wang, P. (2018) · Gene · doi:10.1016/j.gene.2018.07.041 · Cited by 65
Liu, Z., Li, W., Pang, Y., Zhou, Z., Liu, S., Cheng, K., Qin, Q., Jia, Y., & Liu, S. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.10.067 · Cited by 61
“1a left) and GEPIA (Fig.”
MethodSi, X., Xu, F., Xu, F., Wei, M., Ge, Y., & Chenge, S. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109717 · Cited by 63
Yu, Z., Cao, W., Ren, Y., Zhang, Q., & Liu, J. (2020) · Clinical and Translational Medicine · doi:10.1002/ctm2.19 · Cited by 62
Elsafadi, M. A., Manikandan, M., Almalki, S. G., Mahmood, A., Shinwari, T., Vishnubalaji, R., Mobarak, M., Alfayez, M. A., Aldahmash, A. M., Kassem, M. S., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2529-6 · Cited by 61
Integrin Crosstalk Contributes to the Complexity of Signalling and Unpredictable Cancer Cell Fates
Samaržija, I., Dekanić, A., Humphries, J. D., Paradžik, M., Stojanović, N., Humphries, M. J., & Ambriović‐Ristov, A. (2020) · Cancers · doi:10.3390/cancers12071910 · Cited by 64
Ding, G., Xu, X., Li, D., Chen, Y., Wang, W., Ping, D., Jia, S., & Cao, L. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-03019-2 · Cited by 61
Li, Y., Li, X., Li, L., Zhou, R., Sikong, Y., Gu, X., Jin, B.-Y., Li, B., Li, Y., & Zuo, X. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.559486 · Cited by 63
Liu, Y., Qi, J., Dou, Z., Hu, J., Lu, L., Dai, H., Wang, H., & Yang, W. (2019) · Cell Proliferation · doi:10.1111/cpr.12741 · Cited by 71
Wang, S., Alpsoy, A., Sood, S., Ordonez‐Rubiano, S. C., Dhiman, A., Sun, Y., Jiao, G., Krusemark, C. J., & Dykhuizen, E. C. (2021) · ChemBioChem · doi:10.1002/cbic.202100118 · Cited by 60
Identification of Immune-Related lncRNA Prognostic Signature and Molecular Subtypes for Glioblastoma
Yu, W., Ma, Y., Hou, W., Wang, F., Cheng, W., Qiu, F., Wu, P., & Zhang, G. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.706936 · Cited by 65
Yu, T., Zhang, Q., Yu, S.-K., Nie, F., Zhang, M., Wang, Q., & Lu, K. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06008-3 · Cited by 62
Disruption of sugar nucleotide clearance is a therapeutic vulnerability of cancer cells
Doshi, M. B., Lee, N., Tseyang, T., Ponomarova, O., Goel, H. L., Spears, M. E., Li, R., Zhu, L. J., Ashwood, C., Simin, K. J., et al. (2023) · Nature · doi:10.1038/s41586-023-06676-3 · Cited by 61
Cao, J., Ma, J., Sun, L., Li, J., Qin, T., Zhou, C., Cheng, L., Chen, K., Qian, W., Duan, W., et al. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.27266 · Cited by 60
SPOP suppresses prostate cancer through regulation of CYCLIN E1 stability
Ju, L., Zhu, Y., Long, Q., Li, X., Lin, X., Tang, S., Yin, L., Xiao, Y., Wang, X., Li, L., et al. (2018) · Cell Death and Differentiation · doi:10.1038/s41418-018-0198-0 · Cited by 62
Chromogranin-A Expression as a Novel Biomarker for Early Diagnosis of Colon Cancer Patients
Zhang, X., Zhang, H., Shen, B., & Sun, X. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20122919 · Cited by 65
Ahluwalia, P. K., Mondal, A. K., Bloomer, C., Fulzele, S., Jones, K., Ananth, S., Gahlay, G. K., Heneidi, S. G., Rojiani, A. M., Kota, V. K., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20153818 · Cited by 62
Song, C., Yang, H., Luo, H., Qin, Z., Chen, Z., Liu, Y., Lu, S., Sun, H., & Zhou, C. (2019) · Cancer Medicine · doi:10.1002/cam4.2440 · Cited by 60
Liu, M., Wang, R., Sun, X., Liu, Y., Wang, Z., Jin, Y., Kong, X., Liang, S., Liu, Q., Zhao, T., et al. (2020) · Molecular Oncology · doi:10.1002/1878-0261.12643 · Cited by 60
“cn/) were applied to verify VIM expression in GC (Rhodes et al., 2007; Tang et al., 2017).”
MethodZhang, R., Liu, Q., Peng, J., Wang, M., Li, T., Liu, J., Cui, M., Zhang, X., Gao, X., Liao, Q., et al. (2020) · Journal of Cancer · doi:10.7150/jca.40517 · Cited by 69
“html), which is a web server for cancer and normal gene expression profiling[19].”
BackgroundThe proprotein convertase furin is a pro-oncogenic driver in KRAS and BRAF driven colorectal cancer
He, Z., Thorrez, L., Siegfried, G., Meulemans, S. M. P., Évrard, S., Tejpar, S., Khatib, A., & Creemers, J. W. M. (2020) · Oncogene · doi:10.1038/s41388-020-1238-z · Cited by 62
Liang, Y., Deng, Z.-K., Mu-tong, C. H. E. N., Qiu, S.-Q., Xiao, Y., Qi, Y., Xie, Q., Wang, Z.-H., Jia, S., Zeng, D., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.710286 · Cited by 64
“cn/), was utilized to pool and analyse the RNA sequencing expression data from the TCGA and GTEx projects, including 9,736 tumours and 8,587 normal samples, using a standard processing pipeline (14).”
MethodCombinational blockade of MET and PD-L1 improves pancreatic cancer immunotherapeutic efficacy
Li, E., Huang, X., Zhang, G., & Liang, T. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-02055-w · Cited by 61
Pan-cancer analysis identifies ESM1 as a novel oncogene for esophageal cancer
Cui, Y., Guo, W., Li, Y., Shi, J., Ma, S., & Guan, F. (2020) · Esophagus · doi:10.1007/s10388-020-00796-9 · Cited by 64
“GEPIA is an online analysis database which links RNA sequencing data from the TCGA and GTEx datasets [15].”
MethodSignore, M., Alfonsi, R., Federici, G., Nanni, S., Addario, A., Bertuccini, L., Aiello, A., Pace, A. L. D., Sperduti, I., Muto, G., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03909-z · Cited by 62
Lu, X., Wang, J., Wang, W. T., Lu, C., Qu, T., He, X., Liu, X., Guo, R., & Zhang, E. (2022) · Oncogene · doi:10.1038/s41388-022-02292-z · Cited by 60
The Impact of PIK3R1 Mutations and Insulin–PI3K–Glycolytic Pathway Regulation in Prostate Cancer
Chakraborty, G., Nandakumar, S., Hirani, R., Nguyen, B., Stopsack, K. H., Kreitzer, C. K., Rajanala, S. H., Ghale, R., Mazzu, Y. Z., Pillarsetty, N., et al. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-4272 · Cited by 63
Targeting the glutamine-arginine-proline metabolism axis in cancer
Wang, D., Duan, J., Guo, Y., Chen, J., Chen, T.-Q., Wang, J., & Yu, S. (2024) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2024.2367129 · Cited by 61
Tan, Y., Jin, Y., Wu, X., & Ren, Z. (2019) · BMC Molecular Biology · doi:10.1186/s12867-019-0141-z · Cited by 64
Yang, L., Lei, Q., Li, L., Yang, J., Dong, Z., & Cui, H. (2019) · Clinical Epigenetics · doi:10.1186/s13148-019-0778-y · Cited by 60
Comprehensive analysis of the SLC16A gene family in pancreatic cancer via integrated bioinformatics
Yu, S., Wu, Y., Li, C., Qu, Z.-W., Lou, G., Guo, X., Ji, J., Li, N., Guo, M., Zhang, M., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-64356-y · Cited by 64
Self-citationFan, C., Tsai, S., Lin, C., Chang, L., Yang, J., Chen, G., Sher, Y., Wang, S., Hsiao, M., & Chang, W. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101571 · Cited by 64
“In addition, the in silica gene expression analysis revealed a significantly positive correlation between EFHD2 and ABCC1 in NSCLC patients using TCGA RNA-Seq database [29] (Fig.”
MethodLipid metabolism gene-wide profile and survival signature of lung adenocarcinoma
Li, J., Li, Q., Su, Z., Sun, Q., Zhao, Y. M., Feng, T., Jiang, J., Zhang, F., & Ma, H. (2020) · Lipids in Health and Disease · doi:10.1186/s12944-020-01390-9 · Cited by 65
Deng, P., Tan, M., Zhou, W., Chen, C., Xi, Y., Gao, P., Ma, Q., Liang, Y., Chen, M., Tian, L., et al. (2020) · Chemosphere · doi:10.1016/j.chemosphere.2020.129221 · Cited by 63
Xie, Z.-C., Li, T., Gan, B., Gao, X., Gao, L., Chen, G., & Hu, X. (2018) · Pathology - Research and Practice · doi:10.1016/j.prp.2018.03.028 · Cited by 63
Zhang, C., Lian, H., Xie, L., Yin, N., & Cui, Y. (2020) · Biological Chemistry · doi:10.1515/hsz-2019-0430 · Cited by 61
Gao, C., Ren, J., Yu, J. Z., Li, S., Guo, X., & Zhou, Y. (2020) · Annals of Translational Medicine · doi:10.21037/atm-20-1970 · Cited by 58
“cn/) (16) to collate and analyze The Cancer Genome Atlas (TCGA) data with a threshold of P<0.”
BackgroundMethodJiang, Y., Chen, S., Li, Q., Liang, J., Lin, W., Li, J., Liu, Z., Wen, M., Cao, M., & Hong, J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.612139 · Cited by 64
“Gene Expression Profiling Interactive Analysis (GEPIA), Kaplan–Meier (KM) Plotter, and Clinical Proteomic Tumor Analysis Consortium (CPTAC) Database Analysis The online database GEPIA is an interactive web server for the analysis of RNA sequencing expression data from the TCGA and Genotype-Tissue Expression projects,…”
MethodZhang, L., Tao, H., Jiang, L., Zhang, E., Liang, H., & Zhang, B. (2021) · Aging · doi:10.18632/aging.203056 · Cited by 58
“GEPIA is an interactive web that includes 8,587 normal and 9,736 tumors samples [22].”
BackgroundQuigley, M., Rieger, S., Capobianco, E., Wang, Z., Zhao, H., Hewison, M., & Lisse, T. S. (2021) · JBMR Plus · doi:10.1002/jbm4.10572 · Cited by 234
“For example, a meta-analysis of individual cancer data sets using gene expression profiling interactive analysis (GEPIA) shows that DDIT4 mRNA expression is significantly increased in numerous tumor tissues such as cervical squamous cell carcinoma (CESC)(23) (Supplemental Fig.”
BackgroundInfluentialMehraj, U., Aisha, S., Sofi, S., & Mir, M. A. (2022) · Advances in Cancer Biology - Metastasis · doi:10.1016/j.adcanc.2022.100037 · Cited by 61
Anticancer Activity of Erianin: Cancer-Specific Target Prediction Based on Network Pharmacology
Yan, L., Zhang, Z., Liu, Y., Ren, S., Zhu, Z., Wei, L., Feng, J., Duan, T., Sun, X., Xie, T., et al. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.862932 · Cited by 59
“3.2.3 Correlation Analysis Between the Expression of Predicted Targets and Cancer Progression Kaplan-Meier plotter (Nagy et al., 2021) and GEPIA (Tang et al., 2017) were used to assess the correlation of the above targets with overall survival in specific cancer.”
MethodInfluentialSelf-citationCheng, T., Wu, Y., Liu, Z., Yu, Y., Sun, S., Guo, M., Sun, B., & Huang, C. L. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.970950 · Cited by 63
The Clinical Utility of lncRNAs and Their Application as Molecular Biomarkers in Breast Cancer
Arriaga-Canon, C., Contreras‐Espinosa, L., Aguilar-Villanueva, S., Bargalló‐Rocha, E., García-Gordillo, J. A., Cabrera‐Galeana, P., Hernández, C. C., Jiménez-Trejo, F. J., & Herrera, L. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087426 · Cited by 63
Zhao, Z., Wang, Y., Gao, Y., Ju, Y., Zhao, Y., Wu, Z., Gao, S., Zhang, B., Pang, X., Zhang, Y., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2212613120 · Cited by 62
“By analyzing transcriptome data obtained from the Gene Expression Profiling Interactive Analysis ( GEPIA) database ( 40) , we found that”
Hu, K., Wang, Z., Li, J., Zhang, S., Xiao, Z., & Tao, Y. (2018) · Translational Oncology · doi:10.1016/j.tranon.2018.02.010 · Cited by 58
“cn/) was used to generate the Kaplan-Meier analysis of overall survival (OS) and disease-free survival (DFS) stratified by CLEC1B [16].”
MethodPOFUT1 promotes colorectal cancer development through the activation of Notch1 signaling
Du, Y., Li, D., Li, N., Chen, S., Yang, C., Lin, C., Chen, M., Wu, R., Li, X., & Hu, G. M. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-1055-2 · Cited by 59
The iron chelator desferrioxamine synergizes with chemotherapy for cancer treatment
Wang, L., Li, X., Mu, Y., Lu, C., Tang, S., Lu, K., Qiu, X., Wei, A., Cheng, Y., & Wei, W. (2019) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2019.07.008 · Cited by 62
Gou, R., Zhu, L., Zheng, M., Guo, Q., Hu, Y., Li, X., Liu, J., & Lin, B. (2019) · Journal of Translational Medicine · doi:10.1186/s12967-019-2023-z · Cited by 68
Zhao, Z., Liu, Y., Liu, Q., Wu, F., Liu, X., Qu, H., Yuan, Y., Ge, J., Xu, Y., & Wang, H. (2019) · Journal of Cancer · doi:10.7150/jca.33024 · Cited by 61
“cn/) was used to validate the expression and prognosis of the FA metabolic enzymes in ccRCC patients [18].”
MethodMicroRNA-99a Suppresses Breast Cancer Progression by Targeting FGFR3
Long, X., Shi, Y. H., Ye, P., Guo, J., Zhou, Q., & Tang, Y. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2019.01473 · Cited by 58
LncRNA regulation: New frontiers in epigenetic solutions to drug chemoresistance
Zhou, Y., Sun, W. C., Qin, Z., Guo, S., Kang, Y., Zeng, S., & Yu, L. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114228 · Cited by 59
Tang, T., Wang, L., Yang, M., & Zhang, R. (2020) · Molecular Medicine Reports · doi:10.3892/mmr.2020.11542 · Cited by 61
Li, Y., Wu, T., Gong, S., Zhou, H., Yu, L., Liang, M., Shi, R., Wu, Z.-H., Zhang, J., & Li, S. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.570736 · Cited by 58
“The cancer type analysis module contains differential expression analysis and the most differential survival gene screening (14).”
BackgroundMMP1 and MMP9 are potential prognostic biomarkers and targets for uveal melanoma
Wang, T., Zhang, Y., Bai, J., Xue, Y., & Peng, Q. (2021) · BMC Cancer · doi:10.1186/s12885-021-08788-3 · Cited by 61
Wen, D., Lin, P., Pang, Y., Chen, G., He, Y., Dang, Y., & Yang, H. (2018) · Medical Science Monitor · doi:10.12659/msm.907389 · Cited by 57
“To obtain Di erentially expressed LINC00665 GEPIA Potential datasets included through online databases searching. n=3914 Records excluded due to: (1) Not human sapiens records; (2) Not HCC samples; (3) Duplicated records.”
BackgroundMethodInfluentialWang, W., He, J., Lu, H., Kong, Q., & Lin, S. (2020) · Bioscience Reports · doi:10.1042/bsr20193468 · Cited by 60
Zhu, P., Yu, H., Zhou, K., Bai, Y., Qi, R., & Zhang, S. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01618-7 · Cited by 57
“With that, we utilized the GEPIA database to explore the correlations between AHR and RhoA or ROCK1 in ESCA and we found AHR gene was positively correlated with RhoA and ROCK1 gene (Fig.”
BackgroundInfluentialLi, C., Zhao, W., Pan, X., Li, X., Yan, F., Liu, S., Feng, J., & Lu, J. (2020) · Oncogene · doi:10.1038/s41388-020-01427-4 · Cited by 59
“The survival analysis was performed according to the GEPIA website [39].”
MethodSelf-citationIdentification of Arp2/3 Complex Subunits as Prognostic Biomarkers for Hepatocellular Carcinoma
Huang, S., Li, D., Zhuang, L., Sun, L., & Wu, J. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.690151 · Cited by 64
“We further explored the association between Arp2/3 subunits and biomarkers of subsets of TIICs using GEPIA databases (Tang et al., 2017) (http://gepia.cancer-pku.cn/).”
MethodIdentification of HCC Subtypes With Different Prognosis and Metabolic Patterns Based on Mitophagy
Wang, Y., Wang, Z., Sun, J., & Qian, Y. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.799507 · Cited by 66
“The expression of candidate DEGs in different tumor stages and their effect on HCC prognosis were assessed using the GEPIA database (Tang et al., 2017).”
MethodSong, Y., Tian, S., Zhang, P., Zhang, N., Shen, Y., & Deng, J. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2021.708699 · Cited by 59
“cn/), an online tumor data mining server based on the TCGA and GTEx projects (Tang et al., 2017).”
MethodXu, Z., Chen, X., Song, L., Fang, Y., & Yan, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.834595 · Cited by 65
Wei, S., Zhao, Q., Zheng, K., Liu, P., Sha, N., Li, Y., Ma, C., Li, J., Zhuo, L., Liu, G., et al. (2022) · Cell Discovery · doi:10.1038/s41421-022-00423-0 · Cited by 57
Jiang, Y., Xu, Y., Zhu, C., Xu, G., Xu, L., Rao, Z., Zhou, L., Jiang, P., Malik, S., Fang, J., et al. (2023) · Science Signaling · doi:10.1126/scisignal.add2282 · Cited by 59
“…members using mRNA expression data of 369 HCC samples and 50 normal samples from Gepia (Gene Expression Profiling Interactive Analysis from http://gepia.cancer-pku.cn/), which is a web-based tool to deliver fast and customizable functionalities based on TCGA (The Cancer Genome Atlas) data(18).”
MethodYan, N., Xie, W., Wang, D., Fang, Q., Guo, J., Chen, Y., Li, X., Gong, L., Wang, J., Guo, W., et al. (2024) · Genome Medicine · doi:10.1186/s13073-023-01267-3 · Cited by 58
“We calculated the logarithmic fold change based on the normalized median expression of several tumor types and the match normal tissue in TCGA and GTEx data-sets, where the expression data was collected from GEPIA [40].”
MethodSelf-citationSulforaphane metabolites reduce resistance to paclitaxel via microtubule disruption
Wang, Y., Zhou, Y., Zheng, Z., Li, J., Yan, Y., & Wu, W. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-1174-9 · Cited by 57
Metadata
- Authors
- Tang, Z., Li, C., Kang, B., Gao, G., Li, C., & Zhang, Z.
- Affiliations
- Peking University (CN)
- University of California, Santa Cruz (US)
- Corresponding author
- Tang, Zefang
- Li, Chenwei
- Zhang, Zemin
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-04-12
- Volume
- 45
- Issue
- W1
- Pages
- W98-W102
- ISSN
- 0305-1048 (ISSN-L)
- 1362-4962
- PMC
- PMC5570223
- OpenAlex
- W2607129810
- Cited by
- 9,849
- References
- 18
- Citations by year
- 2026: 417 · 2025: 846 · 2024: 1177 · 2023: 1391 · 2022: 1762 · 2021: 1894 · 2020: 1418 · 2019: 689 · 2018: 225 · 2017: 20
- FWCI
- 266.97
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nucleic Acids Research (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (81573022, 31530036)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gene expression and cancer classification
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bioinformatics and Genomic Networks
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer-related molecular mechanisms research
- Keywords
- gene expression profiling, cancer gene expression, RNA sequencing data, TCGA, GTEx, differential expression analysis, dimensionality reduction, web-based analysis tool
- MeSH terms
- Humans, Neoplasm Proteins, Neoplasms, User-Computer Interface, Gene Expression Regulation, Neoplastic, Survival Analysis, Internet, Gene Expression Profiling, Data Mining, Multifactor Dimensionality Reduction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.